254 related articles for article (PubMed ID: 12006803)
21. Inhibition of leukocyte chemotaxis by serum factor in diabetes mellitus: selective depression of cell responses mediated by complement-derived chemoattractants.
Sannomiya P; Pereira MA; Garcia-Leme J
Agents Actions; 1990 Jun; 30(3-4):369-76. PubMed ID: 2167002
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of neutrophil chemotaxis and chemokinesis associated with a plasma protein in aging rats: selective depression of cell responses mediated by complement-derived chemoattractants.
Mello SB; Farsky SH; Sannomiya P; Garcia-Leme J
J Leukoc Biol; 1992 Jan; 51(1):46-52. PubMed ID: 1311013
[TBL] [Abstract][Full Text] [Related]
23. Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.
Kankaanranta H; Moilanen E; Vapaatalo H
Inflammation; 1991 Apr; 15(2):137-43. PubMed ID: 1649132
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
Feltner DE; Smith RH; Marasco WA
J Immunol; 1986 Sep; 137(6):1961-70. PubMed ID: 3018082
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human neutrophil receptor-mediated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70).
Goldman DW; Hannah AL; Goetzl EJ
Immunology; 1985 Jan; 54(1):163-72. PubMed ID: 3838292
[TBL] [Abstract][Full Text] [Related]
26. Systematic single cell analysis of migration and morphological changes of human neutrophils over stimulus concentration gradients.
Yamauchi A; Degawa-Yamauchi M; Kuribayashi F; Kanegasaki S; Tsuchiya T
J Immunol Methods; 2014 Feb; 404():59-70. PubMed ID: 24370750
[TBL] [Abstract][Full Text] [Related]
27. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
[TBL] [Abstract][Full Text] [Related]
28. Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.
Lawrence RH; Sorrelli TC
Clin Exp Immunol; 1992 Aug; 89(2):321-4. PubMed ID: 1322257
[TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
[TBL] [Abstract][Full Text] [Related]
30. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
Ternowitz T
J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil chemotaxis in rhesus macaques (Macaca mulatta).
Gonder JC; Thomas JM; Payne ES
Am J Vet Res; 1986 Apr; 47(4):860-2. PubMed ID: 3963588
[TBL] [Abstract][Full Text] [Related]
32. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
33. Separation of neutrophils from blood in human and laboratory animals and comparison of the chemotaxis.
Sugawara T; Miyamoto M; Takayama S; Kato M
J Pharmacol Toxicol Methods; 1995 Apr; 33(2):91-100. PubMed ID: 7766921
[TBL] [Abstract][Full Text] [Related]
34. Feline polymorphonuclear leukocytes respond chemotactically to leukotriene B4 and activated serum but not to F-Met-Leu-Phe.
Gray GD; Ohlmann GM; Morton DR; Schaub RG
Agents Actions; 1986 Jun; 18(3-4):401-6. PubMed ID: 3019111
[TBL] [Abstract][Full Text] [Related]
35. Optimization of the Transwell® assay for the analysis of neutrophil chemotaxis using flow cytometry to refine the clinical investigation of immunodeficient patients.
Lauwers M; Verschelden G; Boero C; Baleine M; Kerrels V; Cantinieaux B
Clin Immunol; 2022 May; 238():108994. PubMed ID: 35390547
[TBL] [Abstract][Full Text] [Related]
36. Elevated production of neutrophil leukotriene B4 precedes pulmonary failure in critically ill surgical patients.
Davis JM; Meyer JD; Barie PS; Yurt RW; Duhaney R; Dineen P; Shires GT
Surg Gynecol Obstet; 1990 Jun; 170(6):495-500. PubMed ID: 2160738
[TBL] [Abstract][Full Text] [Related]
37. Migration of neutrophils across monolayers of cultured microvascular endothelial cells. An in vitro model of leucocyte extravasation.
Furie MB; Naprstek BL; Silverstein SC
J Cell Sci; 1987 Sep; 88 ( Pt 2)():161-75. PubMed ID: 2961775
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
[TBL] [Abstract][Full Text] [Related]
39. Cardiac-derived neutrophil chemotactic factors: detection in coronary sinus effluents of patients undergoing myocardial revascularization.
Elgebaly SA; Hashmi FH; Houser SL; Allam ME; Doyle K
J Thorac Cardiovasc Surg; 1992 May; 103(5):952-9. PubMed ID: 1314922
[TBL] [Abstract][Full Text] [Related]
40. Relation to chemotactic factor gradients to neutrophil migration and orientation under agarose.
Udén AM; Hafström I; Palmblad J
J Leukoc Biol; 1986 Jan; 39(1):27-35. PubMed ID: 3001211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
